Yu Xu
No.10 Changjiangzhi Rd, Yuzhong District
Daping, China
Daping, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Genomic characterization of DNA damage response pathway mutations reveals their adverse impact on EGFR-TKI efficacy in non-small cell lung cancer.
Journal: Respiratory research
Published: January 05, 2026
Clinical characteristics and prognostic outcomes in KRAS-mutant non-small cell lung cancer: A real-world study with or without COPD comorbidity.
Journal: Cancer treatment and research communications
Published: October 27, 2025
Harmonizing the DESTINY and Broadening the HORIZON of HER2 ADCs in the Face of Next-Generation HER2 TKI for the Treatment Options of HER2 mutations positive (HER2+) NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 25, 2025
DNA damage and repair (DDR) gene mutation profiles in driver gene wild-type advanced non-small cell lung cancer and the predictive role of response to platinum-based chemotherapy.
Journal: Translational lung cancer research
Published: October 22, 2024
Pulmonary Epithelium Cell Fate Determination: Chronic Obstructive Pulmonary Disease, Lung Cancer, or Both.
Journal: American journal of respiratory cell and molecular biology
Published: July 30, 2024
Mutated p53 Promotes the Symmetric Self-Renewal of Cisplatin-Resistant Lung Cancer Stem-Like Cells and Inhibits the Recruitment of Macrophages.
Journal: Journal of immunology research
Published: May 22, 2019
A serine in exon 11 determines the full transcriptional activity of TCF-4 in lung carcinoma cells.
Journal: Biochemical and biophysical research communications
Published: November 18, 2018
PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer.
Journal: PloS one
Published: January 13, 2015
Last Updated: 09/26/2026